Metrochem API Private Limited Metrochem API Private Limited

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Aulos

    Client Virtual Booth

    AULOS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Aulos
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 Main Street Floor 12 Cambridge, Ma 02142
    Telephone
    Telephone
    +1 (617) 294-6790
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aulosbio.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Aulos Au-007 Interim Positive: Phase 1/2 Data At Asco 2024
    Aulos Au-007 Interim Positive: Phase 1/2 Data At Asco 2024

    https://www.businesswire.com/news/home/20240523489073/en

    BUSINESSWIRE
    23 May 2024
    Share Share
    Aulos, Merck KGaA Collaborate On Bavencio + AU-007 Combo
    Aulos, Merck KGaA Collaborate On Bavencio + AU-007 Combo

    https://www.businesswire.com/news/home/20240515322041/en

    BUSINESSWIRE
    15 May 2024
    Share Share
    First Patient Dosed in Phase 2 Portion of Aulos’ Phase 1/2 Trial for AU-007
    First Patient Dosed in Phase 2 Portion of Aulos’ Phase 1/2 Trial for AU-007

    https://www.businesswire.com/news/home/20240125588332/en

    BUSINESSWIRE
    25 Jan 2024
    Share Share
    New Phase 1 Data for Aulos Bioscience’s AU-007 Show Favorable Pharmacodynamic
    New Phase 1 Data for Aulos Bioscience’s AU-007 Show Favorable Pharmacodynamic

    https://www.businesswire.com/news/home/20231014994103/en

    BUSINESSWIRE
    14 Oct 2023
    Share Share
    Aulos Announces Presentation of Updated Safety and Efficacy Data From AU-007
    Aulos Announces Presentation of Updated Safety and Efficacy Data From AU-007

    https://www.businesswire.com/news/home/20230927350421/en

    BUSINESSWIRE
    27 Sep 2023
    Share Share
    Inovio prunes headcount again; Aulos adds to Series A
    Inovio prunes headcount again; Aulos adds to Series A

    https://endpts.com/inovio-prunes-headcount-again-aulos-adds-to-series-a/

    Drew Armstrong ENDPTS
    01 Aug 2023
    Share Share
    Aulos Raises $20M in Series A Extension Financing From Apple Tree Partners
    Aulos Raises $20M in Series A Extension Financing From Apple Tree Partners

    https://www.businesswire.com/news/home/20230801264210/en

    BUSINESSWIRE
    01 Aug 2023
    Share Share
    Interim Results From Phase 1/2 Clinical Trial in Solid Tumor Cancers Demonstrate Aulos Bioscience’s AU-007 is Well Tolerated
    Interim Results From Phase 1/2 Clinical Trial in Solid Tumor Cancers Demonstrate Aulos Bioscience’s AU-007 is Well Tolerated

    https://www.businesswire.com/news/home/20230525005875/en

    BUSINESSWIRE
    25 May 2023
    Share Share
    Aulos Bioscience begins US subject dosing in solid tumours therapy trial
    Aulos Bioscience begins US subject dosing in solid tumours therapy trial

    https://www.clinicaltrialsarena.com/news/aulos-solid-tumours-therapy-trial/

    CLINICAL TRIALS ARENA
    02 Feb 2023
    Share Share
    First U.S. Patient Dosed in Aulos Bioscience’s Phase 1/2 Trial of AU-007
    First U.S. Patient Dosed in Aulos Bioscience’s Phase 1/2 Trial of AU-007

    https://www.businesswire.com/news/home/20230201005821/en

    BUSINESSWIRE
    01 Feb 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    egis-pharmaceuticals-plc-m-2024-06-10

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search